Ascendis Pharma A/S
TransCon hGH
adult growth hormone deficiency (GHD)
Resolved
98days ago
Approval decision · ~ Mar 31, 2026 estimated
What's at stake
A final FDA approval decision on TransCon hGH for adult growth hormone deficiency (GHD) is expected ~ Mar 31, 2026.
Primary source
· SEC 6-K
verified 13h ago
“approval decision anticipated in the first quarter of 2026.”